Shattuck Labs, Inc. STTK
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- +52.33%
- 1 year
- +189.58%
- Open
- 5.67
- Prev close
- 5.72
- Mkt cap
- 558.02M
- Vol
- 951.48K
- Avg vol
- 1.14M
- EPS
- -0.47
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.36
- High
- 5.74
- Forward P/E
- -1.03
- Beta
- 1.86
- Short ratio
- 1.76
- Inst. own
- 74.68%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 1, 2024
- 50-d avg
- 1.23
- 200-d avg
- 4.79
- 1y target
- 1.20
News
2 weeks ago defenseworld.net
Comparing Shattuck Labs (NASDAQ:STTK) & Exicure (NASDAQ:XCUR)
Shattuck Labs (NASDAQ: STTK - Get Free Report) and Exicure (NASDAQ: XCUR - Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two…
2 weeks ago globenewswire.com
Shattuck Labs Announces Two Poster Presentations at UEG Week 2026
AUSTIN, Texas and DURHAM, N.C., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of…
-
2 weeks ago benzinga.com
UBS Initiates Coverage On Shattuck Labs with Buy Rating, Announces Price Target of $17
UBS analyst Alice Nettleton initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Buy rating and announces Price Target of $17.
3 weeks ago defenseworld.net
Shattuck Labs (NASDAQ:STTK) Stock Falls 5.3% – Should You Sell?
Shattuck Labs, Inc. (NASDAQ: STTK - Get Free Report) shares fell 5.3% during mid-day trading on Monday. The company traded as low as $6.33 and last traded at $6.3760. 599,094 shares traded hands…
-
4 weeks ago benzinga.com
Wedbush Maintains Outperform on Shattuck Labs, Raises Price Target to $14
Wedbush analyst David Nierengarten maintains Shattuck Labs (NASDAQ:STTK) with a Outperform and raises the price target from $11 to $14.
4 weeks ago benzinga.com
Abbott To Rally Over 31%? Here Are 10 Top Analyst Forecasts For Friday
Analysts raised targets for ACN, SYNA, ATRC and MPC; cut targets for CSX, NKE, MKC and FHTX, with ATRC downgraded to Hold.
4 weeks ago defenseworld.net
Shattuck Labs (NASDAQ:STTK) Shares Climb 11.9% – Here’s Why
Shattuck Labs, Inc. (NASDAQ: STTK - Get Free Report)'s stock price traded up 11.9% on Wednesday. The stock traded as high as $6.89 and last traded at $7.3150. 221,063 shares were traded during…
-
4 weeks ago benzinga.com
Needham Maintains Buy on Shattuck Labs, Raises Price Target to $19
Needham analyst Joseph Stringer maintains Shattuck Labs (NASDAQ:STTK) with a Buy and raises the price target from $17 to $19.
4 weeks ago defenseworld.net
Comparing MDxHealth (NASDAQ:MDXH) & Shattuck Labs (NASDAQ:STTK)
Shattuck Labs (NASDAQ: STTK - Get Free Report) and MDxHealth (NASDAQ: MDXH - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies…
1 month ago globenewswire.com
Shattuck Labs Announces Phase 2 Clinical Trial of SL-325 in Hidradenitis Suppurativa and Appointment of Shoba Ravichandran, M.D., as Senior Vice President, Clinical Development
– RECEPTIVE-HS1 Phase 2 clinical trial in patients with moderate to severe hidradenitis suppurativa (HS) expected to initiate in 2026; data from the 16-week treatment period expected in the first…
1 month ago defenseworld.net
3,750,000 Shares in Shattuck Labs, Inc. $STTK Purchased by Frazier Life Sciences Management L.P.
Frazier Life Sciences Management L.P. bought a new position in shares of Shattuck Labs, Inc. (NASDAQ: STTK) during the undefined quarter, according to its most recent disclosure with the Securities…
1 month ago defenseworld.net
BlackRock Inc. Invests $27.32 Million in Shattuck Labs, Inc. $STTK
BlackRock Inc. purchased a new stake in Shattuck Labs, Inc. (NASDAQ: STTK) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional…
1 month ago globenewswire.com
Shattuck Labs Announces Participation in Upcoming September Investor Conferences
AUSTIN, Texas and DURHAM, N.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck or the Company) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of…
2 months ago seekingalpha.com
Shattuck Labs: A Receptor-Side Bet On The TL1A Boom
Shattuck Labs pivots to immunology, focusing on DR3-targeted therapies for IBD, notably SL-325, after discontinuing its oncology program. SL-325's Phase 1 data show strong safety, low immunogenicity…
2 months ago fool.com
What Shattuck Labs Stock Topped the Market on Monday
One of them initiated coverage. The company has a very promising lead drug candidate.
-
2 months ago benzinga.com
Raymond James Initiates Coverage On Shattuck Labs with Strong Buy Rating, Announces Price Target of $18
Raymond James analyst Martin Auster initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Strong Buy rating and announces Price Target of $18.
2 months ago zacks.com
Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy?
Does Shattuck Labs, Inc. (STTK) have what it takes to be a top stock pick for momentum investors? Let's find out.
2 months ago defenseworld.net
Geron (NASDAQ:GERN) and Shattuck Labs (NASDAQ:STTK) Head to Head Comparison
Geron (NASDAQ: GERN - Get Free Report) and Shattuck Labs (NASDAQ: STTK - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two…
2 months ago zacks.com
Wall Street Analysts Believe Shattuck Labs (STTK) Could Rally 85.31%: Here's is How to Trade
The consensus price target hints at an 85.3% upside potential for Shattuck Labs (STTK). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings…
-
2 months ago benzinga.com
HC Wainwright & Co. Maintains Buy on Shattuck Labs, Lowers Price Target to $14
HC Wainwright & Co. analyst Joseph Pantginis maintains Shattuck Labs (NASDAQ:STTK) with a Buy and lowers the price target from $18 to $14.
-
2 months ago benzinga.com
Shattuck Labs Q2 EPS $(0.12) Misses $(0.10) Estimate
Shattuck Labs (NASDAQ:STTK) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.10) by 20 percent. This is a 50 percent increase over losses of $(0.24)…
3 months ago fool.com
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday
He was encouraged by the progress of the company's SL-325. This, the biotech's lead drug candidate, is about to enter Phase 2 clinical testing.
3 months ago benzinga.com
This Shattuck Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings…
3 months ago benzinga.com
This Shattuck Labs Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday
Wall Street analysts changed outlook on top names. For full changes, upgrades, downgrades and initiations, see analyst ratings page.
3 months ago 247wallst.com
Here Are Friday’s Top Wall Street Analyst Research Calls: Albertsons, Blue Owl Capital, Cleveland-Cliffs, Chime Financial, Digital Realty, Dover, PayPal Holdings, SpaceX, and More
Markets took a brutal hit Thursday as oil prices, surging interest rates, and Middle East tensions sent every major index deep into the red. See which stocks analysts are upgrading, downgrading, and…
-
3 months ago benzinga.com
JP Morgan Initiates Coverage On Shattuck Labs with Overweight Rating, Announces Price Target of $10
JP Morgan analyst Brian Cheng initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Overweight rating and announces Price Target of $10.
-
3 months ago benzinga.com
Leerink Partners Initiates Coverage On Shattuck Labs with Outperform Rating, Announces Price Target of $16
Leerink Partners analyst Faisal Khurshid initiates coverage on Shattuck Labs (NASDAQ:STTK) with a Outperform rating and announces Price Target of $16.
3 months ago defenseworld.net
Shattuck Labs, Inc. (NASDAQ:STTK) Receives $11.00 Average PT from Brokerages
Shattuck Labs, Inc. (NASDAQ: STTK - Get Free Report) has received an average recommendation of "Moderate Buy" from the ten ratings firms that are presently covering the stock, MarketBeat reports. One…
4 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
4 months ago benzinga.com
Rezolve AI, Bakkt, Seagate And Other Big Stocks Moving Higher On Friday
U.S. stocks were mixed, with the Dow Jones gaining 100 points. Rezolve AI (RZLV) jumped 11.9%, and other stocks such as ALOY and FWRD also rose.
4 months ago benzinga.com
What's Going On With Shattuck Labs Stock Wednesday?
Shattuck Labs ($STTK) shares fluctuate after pricing a $75M public offering at $4.00/share. Get the latest stock updates here.
4 months ago globenewswire.com
Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering
AUSTIN, Texas and DURHAM, N.C., June 10, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development…
-
4 months ago benzinga.com
Shattuck Labs Commences Common Stock Offering; Terms Undisclosed
Shattuck Labs, Inc. ("Shattuck" or the "Company") (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3 blocking…
4 months ago globenewswire.com
Shattuck Labs, Inc. Announces Proposed Public Offering
AUSTIN, Texas and DURHAM, N.C., June 09, 2026 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (“Shattuck” or the “Company”) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development…
-
4 months ago benzinga.com
Citigroup Maintains Buy on Shattuck Labs, Raises Price Target to $18
Citigroup analyst Yigal Nochomovitz maintains Shattuck Labs (NASDAQ:STTK) with a Buy and raises the price target from $7 to $18.
-
4 months ago benzinga.com
Shattuck Labs Announces Total Expected Proceeds Of ~$59.4M From Exercised Warrants
Shattuck Labs, Inc. (Shattuck) (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of potentially first-in-class monoclonal and bispecific DR3-blocking antibodies for the…
4 months ago benzinga.com
Crude Oil Gains Over 1%; Motorcar Parts Of America Shares Surge After Q4 Earnings
US stocks rose with Nasdaq up 400 points. Dow up 0.32%, Nasdaq up 1.55%, S&P 500 up 0.94%. Tech shares rose, communication services fell. Motorcar Parts of America stock jumped 37% on strong…
4 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
4 months ago benzinga.com
Merlin, Concrete Pumping Holdings, And Krispy Kreme And Other Big Stocks Moving Higher On Friday
U.S. stocks trade lower on Friday, Nasdaq down 425 points. Merlin shares rise 35.93% after successful CDR, other big stocks also record gains.
4 months ago benzinga.com
Concrete Pumping Holdings Reports Blowout Q2 Results, Joins ServiceTitan and Other Big Stocks Moving Higher in Friday's Pre-Market Session
US stock futures higher, Nasdaq futures down. Concrete Pumping Holdings shares up 28.94% pre-market. Other stocks moving in pre-market.
-
4 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
6 months ago benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's After-Market Session
-
9 months ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
11 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Wednesday's Intraday Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
12 Health Care Stocks Moving In Monday's After-Market Session
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
1 year ago benzinga.com
Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Why Levi Strauss Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket